Location History:
- Derbyshire, GB (2005)
- Hope Valley, GB (2010)
Company Filing History:
Years Active: 2005-2010
Title: Ian Stratford: Innovator in Drug Targeting Technologies
Introduction
Ian Stratford is a notable inventor based in Hope Valley, GB. He has made significant contributions to the field of drug targeting, with a focus on developing methods that enhance the delivery of therapeutic agents to specific areas within the body. His innovative approaches aim to address various medical conditions, showcasing his commitment to advancing healthcare solutions.
Latest Patents
Ian Stratford holds two patents that reflect his expertise in drug targeting. The first patent introduces a method for targeting drugs to hypoxic and/or ischemic tissues. This invention links the desired drug species to a non-cytotoxic bioreductive carrier, allowing for precise delivery. The compounds developed through this patent are particularly effective in treating conditions such as rheumatoid arthritis, diabetes, atherosclerosis, stroke, sepsis, Alzheimer's disease, cancer, kidney disease, and more.
The second patent focuses on a bioreductive conjugate that comprises a bioreductive moiety linked to at least one therapeutic agent. This conjugate is designed to release the therapeutic agent through a bioreduction process, which involves the elimination of a bond and subsequent intramolecular cyclization. The innovative design of these conjugates enhances their therapeutic potential and effectiveness.
Career Highlights
Ian Stratford is affiliated with the University of Manchester, where he continues to contribute to research and development in the field of drug targeting. His work is characterized by a strong emphasis on creating novel bioreductive conjugates that can significantly improve treatment outcomes for various diseases.
Collaborations
Ian collaborates with esteemed colleagues such as David Blake and Declan Naughton. Their combined expertise fosters a dynamic research environment that encourages innovation and the development of groundbreaking therapeutic solutions.
Conclusion
Ian Stratford's contributions to drug targeting technologies exemplify his dedication to improving healthcare through innovative inventions. His patents and collaborative efforts position him as a key figure in the advancement of medical treatments.